Therapeutic vaccine for chronic diseases after the COVID-19 Era

There is currently a respiratory disease outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After rapid development, RNA vaccines and adenoviral vector vaccines were approved within a year, which has demonstrated the strong impact of preventing infectious diseases using...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagami, Hironori, Hayashi, Hiroki, Shimamura, Munehisa, Rakugi, Hiromi, Morishita, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184354/
https://www.ncbi.nlm.nih.gov/pubmed/34099884
http://dx.doi.org/10.1038/s41440-021-00677-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184354/
https://www.ncbi.nlm.nih.gov/pubmed/34099884
http://dx.doi.org/10.1038/s41440-021-00677-3

Ejemplares similares